Repligen Corporation (RGEN): Share Price, Stock Analysis, Annual Report | Value Research Get Repligen Corporation (RGEN)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Medical Devices & Equipment

Repligen Corporation (RGEN)

NASDAQ: RGEN

  • Market Capitalisation info

    $13,948 Mln


  • 12 Month Earnings info

    $146 Mln

  • Price to Earnings info

    94.49

$251.35

As on 12-Aug-2022 16:00 EDT

up-down-arrow $4.861.97%

  • Prev Close info

    $246.49

  • Day's Openinfo

    $248.00

  • Today's Highinfo

    $251.62

  • Today's Lowinfo

    $243.08

  • Today's Volumeinfo

    451,645

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Repligen (RGEN)
-5.09 45.61 77.09 0.68 39.88 43.59 49.03
S&P BSE Sensex
2.08 9.32 9.94 9.05 16.53 13.76 12.97
S&P Midcap 400
-7.99 14.01 11.37 -4.63 11.21 8.85 10.52
As on 12-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Repligen (RGEN)
38.20 107.17 75.39 45.07 17.72 8.94 42.88
S&P Midcap 400
23.21 11.81 24.05 -12.43 14.45 18.73 -3.71
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Pres, CEO & Director

        Mr. Anthony J. Hunt

        Chief Financial Officer

        Mr. Jon K. Snodgres

        Headquarters

        Waltham, MA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $13,947.71 Mln

        • Revenue (TTM) info

          $734.10 Mln

        • Earnings (TTM) info

          $145.81 Mln

        • Cash info

          $584.64 Mln

        • Total Debt info

          $393.58 Mln

        • Insider's Holding

          6.74%

        • Liquidity info

          Low

        • 52 Week range info

          $137.21 - 327.32

        • Shares outstanding info

          55,433,200

        • 10 Years Aggregate:

          CFO: $379.42 Mln

          EBITDA: $522.62 Mln

          Net Profit: $314.04 Mln

        About The Company

        • Business

          Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.

        • IPO Date

          26-Mar-1990

        • Pres, CEO & Director

          Mr. Anthony J. Hunt

        • Chief Financial Officer

          Mr. Jon K. Snodgres

        • Listing info

          NASDAQ: RGEN

        • Country

          United States

        • Headquarters info

          Waltham, MA

        • Website info

          https://www.repligen.com